Limited Competition for NIH-Industry Pilot Program: Discovering New Therapeutic Uses for Existing Molecules (UH2/UH3)
The National Center for Advancing Translational Sciences (NCATS) seeks to develop a therapeutics discovery pilot program that will explore new therapeutic uses for proprietary drug candidates (Agents) across a broad range of human diseases. This innovative program will match Agents and associated data from pharmaceutical company partners with the best ideas for new therapeutic uses from the biomedical research community.
General information about this opportunity
Last Known Status
Deleted 01/17/2013 (Archived.)
Program Number
RFA-TR-12-004 Federal Agency/Office
Agency: Department of Health and Human ServicesOffice: National Institutes of Health
Type(s) of Assistance Offered
Cooperative Agreement Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Other Eligible Applicants include the following: This FOA is a limited competition for those applicants who submitted a pre-application in response to PAR-12-203 [X02] and have been notified of the opportunity to submit a UH2/UH3 application. What is the process for applying and being award this assistance?
Deadlines
12/17/2012 Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements. Who do I contact about this opportunity?
Headquarters Office
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Website Address
http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-12-004.html
E-mail Address
FBOWebmaster@OD.NIH.GOV
Financial Information
Obligations
$20,000,000.00
